NKG2D engagement on human NK cells leads to DNAM‐1 hypo‐responsiveness through different converging mechanisms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NKG2D engagement on human NK cells leads to DNAM‐1 hypo‐responsiveness through different converging mechanisms

Published:2022-12-08 Issue:2 Volume:53 Page:2250198
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur J Immunol

Author:

Milito Nadia D.¹,Zingoni Alessandra¹,Stabile Helena¹,Soriani Alessandra¹,Capuano Cristina²,Cippitelli Marco¹,Gismondi Angela¹,Santoni Angela¹³,Paolini Rossella¹^ORCID,Molfetta Rosa¹^ORCID

Affiliation:

1. Laboratory affiliated to Istituto Pasteur Italia‐Fondazione Cenci Bolognetti Department of Molecular Medicine Sapienza University of Rome Rome Italy

2. Department of Experimental Medicine Sapienza University of Rome Rome Italy

3. IRCCS Neuromed Pozzilli Isernia Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Sapienza Università di Roma

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202250198

Reference50 articles.

1. Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition

2. Natural killer cells and other innate lymphoid cells in cancer

3. Exploiting NK Cell Surveillance Pathways for Cancer Therapy

4. NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy

5. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment;Cancers;2023-09-18

2. Therapeutic Anti-KIR Antibody of 1–7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom;International Journal of Molecular Sciences;2023-09-16

3. CD155 and Its Receptors as Targets for Cancer Therapy;International Journal of Molecular Sciences;2023-08-19

4. SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses;Frontiers in Cell and Developmental Biology;2023-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3